Cargando…

Pregnancy in juvenile idiopathic arthritis: maternal and foetal outcome, and impact on disease activity

OBJECTIVE: This retrospective cohort study describes the modulation of disease activity during gestation and in the year following delivery as well as maternal and neonatal outcomes in a monocentric cohort of women with juvenile idiopathic arthritis (JIA). METHODS: Disease activity was assessed usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerosa, Maria, Chighizola, Cecilia Beatrice, Pregnolato, Francesca, Pontikaki, Irene, Luppino, Angela Flavia, Argolini, Lorenza Maria, Trespidi, Laura, Ossola, Manuela Wally, Ferrazzi, Enrico M., Caporali, Roberto, Cimaz, Rolando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905061/ https://www.ncbi.nlm.nih.gov/pubmed/35282569 http://dx.doi.org/10.1177/1759720X221080375

Ejemplares similares

Juvenile Idiopathic Arthritis, Uveitis and Multiple Sclerosis: Description of Two Patients and Literature Review
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2022)

Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases
por: Cavalli, Silvia, et al.
Publicado: (2022)

Hyaluronic Acid Injections in the Treatment of Osteoarthritis Secondary to Primary Inflammatory Rheumatic Diseases: A Systematic Review and Qualitative Synthesis
por: De Lucia, Orazio, et al.
Publicado: (2020)

Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
por: Rosina, Silvia, et al.
Publicado: (2021)

Giant leiomyoma management during elective cesarean section: a case report
por: Cassardo, Ottavio, et al.
Publicado: (2023)

Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the Road
por: Beltagy, Asmaa, et al.
Publicado: (2021)

Psoriatic Juvenile Idiopathic Arthritis Associated with Uveitis: A Case Report
por: Moretti, Davide, et al.
Publicado: (2013)

Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members
por: Marino, Achille, et al.
Publicado: (2020)

The Prevalence and Clinical Impact of Adenomyosis in Pregnancy-Related Hysterectomy
por: Orsi, Michele, et al.
Publicado: (2022)

In vitro effects of etanercept on the development of different T cell subsets in patients with juvenile idiopathic arthritis
por: Cimaz, Rolando, et al.
Publicado: (2011)

Th17 and Th1 Lymphocytes in Oligoarticular Juvenile Idiopathic Arthritis
por: Maggi, Laura, et al.
Publicado: (2019)

Localized scleroderma in a cohort of juvenile idiopathic arthritis children
por: Giani, Teresa, et al.
Publicado: (2014)

The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis
por: Giani, Teresa, et al.
Publicado: (2019)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
por: Pontikaki, I, et al.
Publicado: (2008)

Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients
por: Maggi, Laura, et al.
Publicado: (2016)

Course, outcome and complications in a single centre cohort of 53 indian children with systemic onset juvenile idiopathic arthritis with a minimum follow up of 3 years
por: Dewoolkar, Mansi, et al.
Publicado: (2014)

The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2020)

Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients
por: Capone, Manuela, et al.
Publicado: (2016)

Serum Amyloid A Circulating Levels and Disease Activity in Patients with Juvenile Idiopathic Arthritis
por: Cantarini, Luca, et al.
Publicado: (2012)

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting
por: Ferrara, Giovanna, et al.
Publicado: (2018)

Clinical and serological features of juvenile systemic lupus erythematosus in an italian tertiary centre of pediatric rheumatology
por: Pontikaki, Irene, et al.
Publicado: (2014)

Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy
por: Costi, Stefania, et al.
Publicado: (2020)

Editorial: New Therapies in the Field of Rheumatology
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2020)

Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort
por: Gerosa, Maria, et al.
Publicado: (2022)

sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19
por: Soldavini, Chiara Maria, et al.
Publicado: (2022)

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
por: Salmaso, A, et al.
Publicado: (2008)

Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review
por: Iannone, Claudia, et al.
Publicado: (2023)

Collaboration in long term follow-up of juvenile idiopathic arthritis
por: Larbre, JP, et al.
Publicado: (2008)

Increased Immunity against the Oral Germs Porphyromonas gingivalis and Prevotella intermedia in Different Categories of Juvenile Idiopathic Arthritis
por: Zekre, Franck, et al.
Publicado: (2022)

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
por: Sota, Jurgen, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year
por: Ramirez, Giuseppe A., et al.
Publicado: (2021)

Long Term Experience in Patients With JIA-Associated Uveitis in a Large Referral Center
por: Marelli, Luca, et al.
Publicado: (2021)

Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers
por: Meroni, Pier Luigi, et al.
Publicado: (2014)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients
por: Ramirez, Giuseppe A., et al.
Publicado: (2020)

Role of Ultrasound Evaluation of Temporomandibular Joint in Juvenile Idiopathic Arthritis: A Systematic Review
por: Marino, Achille, et al.
Publicado: (2022)

Efficacy and safety of tocilizumab in european children with systemic onset juvenile idiopathic arthritis
por: Nemiche, O, et al.
Publicado: (2011)

Editorial: Therapeutic Implications for Pregnant Women With Systemic Autoimmune Diseases and Their Children
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2021)

Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature
por: Baldo, Francesco, et al.
Publicado: (2021)

Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status
por: Di Paola, Monica, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t2oe12qug4hgmddbqa4338ivkd